Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Neurogastroenterol Motil. 2013 Feb 17;25(5):427–e301. doi: 10.1111/nmo.12091

Table 4.

CHARACTERISTICS OF GASTROPARESIS PATIENTS WITH PREDOMINANT PAIN/DISCOMFORT VS. PREDOMINANT NAUSEA/VOMITING

Characteristic Predominant
Abdominal
Pain/Discomfort
N=81

Predominant
Nausea/Vomiting
N=172
Difference
(95% CI)*
P
Demographic and clinical factors Age at enrollment (years) 41.3±12.9 40.4±14.2 0.9 (−2.8, 4.6) 0.63
Female sex 68 (84%) 144 (84%) 0% (−10%, 11%) 1.00
Hispanic ethnicity 4 (5%) 8 (5%) 0% (−6%, 7%) 1.00
Race:
White
Black
Other
 
66 (84%)
11 (14%)
2 (2%)
 
149 (88%)
16 (10%)
4 (2%)
 
−4% (−15%, 6%)
4% (−5%, 14%)
0% (−5%, 5%)
0.55
Gastroparesis etiology:
Diabetic
Idiopathic
 
23 (28%)
58 (72%)
 
57 (33%)
115 (67%)
 
−5% (−18%, 8%)
5% (−8%, 18%)
0.45
Acute symptom onset 42 (52%) 100 (58%) −6% (−20%, 8%) 0.40
Initial infectious prodrome 12 (15%) 32 (19%) −4% (−14%, 7%) 0.46
Gastroparesis severity measures Clinician-rated severity:
Grade 1
Grade 2
Grade 3
 
7 (9%)
39 (49%)
34 (42%)
 
15 (9%)
88 (52%)
67 (39%)
 
0% (−9%, 8%)
−3% (−17%, 11%)
3% (−11%, 17%)
0.90
GCSI:
Overall
Nausea/vomiting subscale
Postprandial fullness/early satiety
subscale
Bloating subscale
 
2.9±1.0
2.3±1.3
3.5±1.1

2.9±1.6
 
3.2±0.9
3.3±1.3
3.5±1.0

2.9±1.6
 
−0.4 (−0.6, −0.1)
−1.0 (−1.3, −0.7)
0 (−0.3, 0.2)

−0.1 (−0.5, 0.3)
 
0.003
<0.001
0.74

0.69
PAGI-SYM:
Upper abdominal pain
Upper abdominal discomfort
Lower abdominal pain
Lower abdominal discomfort
Constipation
Diarrhea
 
4.1±1.1
4.1±1.1
2.5±1.6
2.5±1.7
2.5±1.6
1.7±1.6
 
2.9±1.8
3.1±1.6
2.2±1.7
2.3±1.7
2.4±1.8
2.0±1.8
 
1.2 (0.8, 1.6)
1.0 (0.6, 1.3)
0.4 (−0.1, 0.8)
0.3 (−0.2, 0.7)
0.1 (−0.4, 0.5)
−0.3 (−0.8, 0.1)
 
<0.001
<0.001
0.114
0.26
0.78
0.159
Quality of life measures PAGI-QOL 2.2±1.1 2.4±1.1 −0.2 (−0.5, 0.0) 0.095
SF-36:
Physical component
Mental component
 
31.6±8.3
35.3±10.8
 
32.5±10.0
36.0±12.9
 
−0.9 (−3.4, 1.6)
−0.7 (−4.0, 2.5)
 
0.49
0.65
BPI:
Overall pain interference score
General activity
Mood
Walking ability
Normal work
Relations with people
Sleep
Enjoyment of life
 
6.2±2.2
6.5±2.7
6.6±2.6
5.1±2.9
6.5±2.7
5.4±3.1
6.5±3.2
7.0±2.9
 
5.4±2.8
5.5±3.3
5.9±3.3
4.0±3.3
6.1±3.4
4.7±3.4
5.6±3.6
6.0±3.4
 
0.8 (0.1, 1.6)
1.0 (0.2, 1.9)
0.8 (−0.1, 1.7)
1.0 (0.2, 1.9)
0.4 (−0.5, 1.3)
0.7 (−0.3, 1.6)
0.9 (−0.1, 1.8)
1.0 (0.0, 1.9)
 
0.026
0.019
0.067
0.022
0.37
0.167
0.067
0.039
Parameters of psychological dysfunction BDI 20.0±9.6 19.9±11.2 0.1 (−2.8, 2.9) 0.98
STAI:
Y1 state anxiety
Y2 trait anxiety
 
47.4±12.8
45.7±11.2
 
46.5±13.5
45.1±12.6
 
0.9 (−2.6, 4.4)
0.6 (−2.6, 3.8)
 
0.62
0.71
Gastric emptying Gastric retention (%):
2 hour
4 hour
 
63.6±17.9
31.9±21.1
 
63.5±17.7
32.3±21.9
 
0.1 (−4.6, 4.8)
−0.5 (−0.6, 5.3)
 
0.97
0.88
Medication use Prokinetics
Antiemetics
Opiates
Neuropathic pain modulators
Antidepressants
43 (53%)
43 (53%)
49 (60%)
18 (22%)
34 (42%)
103 (60%)
130 (76%)
68 (40%)
34 (20%)
67 (39%)
−7% (−21%, 7%)
−22% (−36%, −9%)
20% (7%, 35%)
2% (−9%, 14%)
3% (−11%, 17%)
0.31
<0.001
0.002
0.65
0.65

All data are mean±SD or N (%)

*

Differences in means (95% CI) are presented for continuous variables and differences in proportions (95% CI) are presented for categorical variables. The 95% CIs for differences in means were based on the t-distribution; intervals for differences in proportions used the Newcombe score method with continuity correction.

GCSI: Gastroparesis Cardinal Symptom Index

PAGI-SYM: Patient Assessment of Upper Gastrointestinal Disorders Symptoms

PAGI-QOL: Patient Assessment of Upper Gastrointestinal Disorders Quality of Life

SF-36: Short Form-36

BPI: Brief Pain Inventory

BDI: Beck Depression Inventory

STAI: State and Trait Anxiety Inventory